KNSA
Price
$28.93
Change
+$0.13 (+0.45%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
2.1B
19 days until earnings call
VYGR
Price
$3.54
Change
+$0.37 (+11.64%)
Updated
Jul 10, 02:15 PM (EDT)
Capitalization
192.02M
21 days until earnings call
Interact to see
Advertisement

KNSA vs VYGR

Header iconKNSA vs VYGR Comparison
Open Charts KNSA vs VYGRBanner chart's image
Kiniksa Pharmaceuticals International
Price$28.93
Change+$0.13 (+0.45%)
Volume$9.37K
Capitalization2.1B
Voyager Therapeutics
Price$3.54
Change+$0.37 (+11.64%)
Volume$442
Capitalization192.02M
KNSA vs VYGR Comparison Chart in %
Loading...
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KNSA vs. VYGR commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNSA is a StrongBuy and VYGR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (KNSA: $28.80 vs. VYGR: $3.47)
Brand notoriety: KNSA and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KNSA: 112% vs. VYGR: 164%
Market capitalization -- KNSA: $2.1B vs. VYGR: $192.02M
KNSA [@Biotechnology] is valued at $2.1B. VYGR’s [@Biotechnology] market capitalization is $192.02M. The market cap for tickers in the [@Biotechnology] industry ranges from $314.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNSA’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 2 green FA rating(s).

  • KNSA’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 2 green, 3 red.
According to our system of comparison, both KNSA and VYGR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KNSA’s TA Score shows that 4 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • KNSA’s TA Score: 4 bullish, 5 bearish.
  • VYGR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VYGR is a better buy in the short-term than KNSA.

Price Growth

KNSA (@Biotechnology) experienced а +4.96% price change this week, while VYGR (@Biotechnology) price change was +8.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.89%. For the same industry, the average monthly price growth was +16.25%, and the average quarterly price growth was +20.89%.

Reported Earning Dates

KNSA is expected to report earnings on Nov 04, 2025.

VYGR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+9.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KNSA($2.1B) has a higher market cap than VYGR($192M). KNSA has higher P/E ratio than VYGR: KNSA (164.54) vs VYGR (6.00). KNSA YTD gains are higher at: 45.602 vs. VYGR (-38.801). KNSA has higher annual earnings (EBITDA): -14.23M vs. VYGR (-97.25M). KNSA has more cash in the bank: 268M vs. VYGR (236M). KNSA has less debt than VYGR: KNSA (9.92M) vs VYGR (42M). KNSA has higher revenues than VYGR: KNSA (481M) vs VYGR (67M).
KNSAVYGRKNSA / VYGR
Capitalization2.1B192M1,095%
EBITDA-14.23M-97.25M15%
Gain YTD45.602-38.801-118%
P/E Ratio164.546.002,742%
Revenue481M67M718%
Total Cash268M236M114%
Total Debt9.92M42M24%
FUNDAMENTALS RATINGS
KNSA vs VYGR: Fundamental Ratings
KNSA
VYGR
OUTLOOK RATING
1..100
511
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
66100
SMR RATING
1..100
9195
PRICE GROWTH RATING
1..100
4465
P/E GROWTH RATING
1..100
110
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (33) in the Biotechnology industry is somewhat better than the same rating for KNSA (85) in the Pharmaceuticals Major industry. This means that VYGR’s stock grew somewhat faster than KNSA’s over the last 12 months.

KNSA's Profit vs Risk Rating (66) in the Pharmaceuticals Major industry is somewhat better than the same rating for VYGR (100) in the Biotechnology industry. This means that KNSA’s stock grew somewhat faster than VYGR’s over the last 12 months.

KNSA's SMR Rating (91) in the Pharmaceuticals Major industry is in the same range as VYGR (95) in the Biotechnology industry. This means that KNSA’s stock grew similarly to VYGR’s over the last 12 months.

KNSA's Price Growth Rating (44) in the Pharmaceuticals Major industry is in the same range as VYGR (65) in the Biotechnology industry. This means that KNSA’s stock grew similarly to VYGR’s over the last 12 months.

KNSA's P/E Growth Rating (1) in the Pharmaceuticals Major industry is in the same range as VYGR (10) in the Biotechnology industry. This means that KNSA’s stock grew similarly to VYGR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KNSAVYGR
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 10 days ago
80%
Bearish Trend 21 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
KNSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACNFF26.321.88
+7.67%
Amsterdam Commodities N.V.
NRXBF0.520.03
+6.25%
NUREXONE BIOLOGIC INC
ABNAF0.05N/A
N/A
Aben Gold Corp
ELEZF31.02N/A
N/A
Endesa S.A.
YZCFF0.07N/A
N/A
Sinopec Yizheng Chem Fibre Co Ltd

KNSA and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNSA has been loosely correlated with ABVC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if KNSA jumps, then ABVC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNSA
1D Price
Change %
KNSA100%
+5.84%
ABVC - KNSA
40%
Loosely correlated
-1.27%
COYA - KNSA
40%
Loosely correlated
+3.67%
CPRX - KNSA
37%
Loosely correlated
+4.22%
BEAM - KNSA
36%
Loosely correlated
+5.71%
AMRN - KNSA
36%
Loosely correlated
+2.97%
More